Ligand validation:4AMJ

2CV: HEGA-10

2CV is a Ligand Of Interest in 4AMJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4AMJ_2CV_B_1363	18%	79%	0.178	0.882	0.39	0.47	-	-	0	0	35%	0.3462
4AMJ_2CV_A_1362	18%	85%	0.181	0.91	0.53	0.23	-	-	0	0	19%	19.23
4AMJ_2CV_A_1363	12%	82%	0.192	0.836	0.61	0.21	-	-	0	0	35%	0.3462
4AMJ_2CV_A_1364	10%	63%	0.23	0.767	0.47	0.95	-	1	0	0	81%	0.8077
4AMJ_2CV_B_1362	10%	75%	0.303	0.9	0.48	0.5	-	-	0	0	46%	0.4615
4AMJ_2CV_A_1368	7%	66%	0.251	0.768	0.69	0.63	-	-	0	0	62%	0.6154
4AMJ_2CV_B_1359	6%	58%	0.275	0.74	0.71	0.91	1	1	0	0	77%	0.7692
4AMJ_2CV_A_1367	4%	79%	0.275	0.758	0.43	0.43	-	-	1	0	46%	0.4615
4AMJ_2CV_A_1365	4%	70%	0.34	0.808	0.62	0.53	-	-	2	0	54%	0.5385
4AMJ_2CV_A_1361	3%	60%	0.289	0.703	0.69	0.83	-	-	1	0	62%	0.6154
4AMJ_2CV_A_1366	3%	83%	0.191	0.657	0.62	0.18	-	-	0	0	27%	0.2692
4AMJ_2CV_B_1364	1%	78%	0.315	0.489	0.54	0.36	-	-	0	0	38%	0.3846
6H7L_2CV_A_402	60%	65%	0.153	0.939	0.28	1.03	-	1	0	0	100%	1
6H7O_2CV_A_403	52%	67%	0.172	0.931	0.38	0.88	-	2	0	0	100%	1
2Y01_2CV_A_501	38%	55%	0.215	0.92	0.63	1.11	1	1	0	0	100%	1
6H7M_2CV_A_501	34%	57%	0.225	0.908	0.36	1.25	-	3	0	0	100%	1
2Y03_2CV_B_502	31%	83%	0.165	0.981	0.44	0.34	-	-	0	0	19%	19.23
2YCW_2CV_A_1361	28%	69%	0.224	0.875	0.64	0.56	-	-	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.